reference
Topical silymarin administration is effective for the prevention of acute radiodermatitis in breast cancer patients, according to a 2019 randomized, double-blind, placebo-controlled clinical trial by Karbasforooshan et al.

Authors

Sources

Referenced by nodes (2)